Diseases, Conditions, Syndromes

Overactive bladder common in postacute COVID-19 syndrome

Overactive bladder (OAB) symptoms are common in patients recovering from postacute COVID-19 syndrome (PACS), according to a study published online Oct. 26 in the Journal of Multidisciplinary Healthcare.

Other

FDA approves Botox competitor that lasts longer

People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades.

Gerontology & Geriatrics

Urinary incontinence poses burden to long-term care

The impact and management of urinary incontinence (UI) related to overactive bladder is a substantial burden to long-term care (LTC) residents and staff, according to a study published online July 1 in the Journal of Gerontological ...

Obstetrics & gynaecology

Overactive bladder and urinary incontinence worsen with age

If you're feeling more sudden urges to run to the bathroom as you age, you're not alone. A new study suggests postmenopausal women aged 45 to 54 years are more likely to have overactive bladder (OAB) syndrome. Additionally, ...

Medications

VESIcare LS approved for neurogenic detrusor overactivity

VESIcare LS (solifenacin succinate) oral suspension is now approved to treat neurogenic detrusor overactivity (NDO) in children 2 years and older, the U.S. Food and Drug Administration announced Tuesday.

page 3 from 9